ALYGLO
Mark Identification

ALYGLO

Serial Number

90160114

Filing Date

Sep 4, 2020

Registration Date

Nov 26, 2024

Trademark by

GC BIOPHARMA CORP.

Active Trademark

Classification Information

Blood plasma derivatives for medical purposes, namely, immune globulins including Rh immune globulin; Immunoglobulin reparations, namely, pharmaceutical immunoglobulin preparations for treatment of primary humoral immunodeficiency, Kawasaki disease, Guillain-Barre syndrome, common variable immune deficiency, X-linked agammaglobulinemia (XLA), hyper immunoglobulin M syndromes, Wiskott Aldrich Syndrome and severe combined immune deficiency (SCID), agammaglobulinemia, hypogammaglobulinemia, cardiovascular disease, inflammatory diseases, immunological disorders, bacterial infections, acute serious bacterial infection, chronic inflammatory demyelinating polyneuropathy (CIDP) and immune thrombocytopenic purpura (ITP); all the foregoing for patient treatment by injection or in liquid form by health professional

Pharmaceuticals